These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32850070)

  • 21. Clinical Review: Loperamide Toxicity.
    Wu PE; Juurlink DN
    Ann Emerg Med; 2017 Aug; 70(2):245-252. PubMed ID: 28506439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Torsade de pointes following repeated massive loperamide ingestions].
    Myllymäki L; Westerbergh J; Carlsson H; Höjer J
    Lakartidningen; 2020 Jan; 117():. PubMed ID: 32016923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loperamide abuse cardiotoxicity. Should loperamide still be an over the counter medication?
    Idris A; Mihora DC; Kaye K
    Am J Emerg Med; 2018 Sep; 36(9):1716.e1-1716.e3. PubMed ID: 29779679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loperamide Overdose.
    Arnold C; Martinez Martinez CJ
    Cureus; 2019 May; 11(5):e4753. PubMed ID: 31363435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.
    Uvelin A; Pejaković J; Mijatović V
    J Anesth; 2017 Jun; 31(3):413-423. PubMed ID: 28229241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac Arrhythmia Secondary to Loperamide Abuse and Toxicity.
    Ali M; Mujahid A; Bulathsinghala CP; Surani S
    Cureus; 2020 Feb; 12(2):e6936. PubMed ID: 32190488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loperamide metabolite-induced cardiomyopathy and QTc prolongation.
    Bhatti Z; Norsworthy J; Szombathy T
    Clin Toxicol (Phila); 2017 Aug; 55(7):659-661. PubMed ID: 28349724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loperamide-induced cardiogenic syncope: a case report of a life-threatening presentation of an over-the-counter drug.
    Hegde V; Dalia T; Tayeb T; Cotter E; Vidic A
    Eur Heart J Case Rep; 2023 Feb; 7(2):ytad059. PubMed ID: 36819880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CME ECC 66: Torsade de Pointes: The Danger of a Rotating Heart Axis].
    Markendorf S; Saguner AM; Brunckhorst C
    Praxis (Bern 1994); 2020 Sep; 109(12):944-951. PubMed ID: 32933390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CME ECG 66/Answers: Torsade de Pointes: The Danger of a Rotating Heart Axis].
    Markendorf S; Saguner AM; Brunckhorst C
    Praxis (Bern 1994); 2020; 109(13):1035-1038. PubMed ID: 33050812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diphenhydramine induced QT prolongation and torsade de pointes: An uncommon effect of a common drug.
    Husain Z; Hussain K; Nair R; Steinman R
    Cardiol J; 2010; 17(5):509-11. PubMed ID: 20865683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loperamide: an emerging drug of abuse and cause of prolonged QTc.
    Whittaker G; Newman J
    Clin Med (Lond); 2021 Mar; 21(2):150-152. PubMed ID: 33762378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loperamide induced cardiac arrhythmia successfully supported with veno-arterial ECMO (VA-ECMO), molecular adsorbent recirculating system (MARS) and continuous renal replacement therapy (CRRT).
    Parker BM; Rao T; Matta A; Quitanna M; Reynolds HN; Stein DM; Haase D
    Clin Toxicol (Phila); 2019 Nov; 57(11):1118-1122. PubMed ID: 30806091
    [No Abstract]   [Full Text] [Related]  

  • 35. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ventricular tachyarrhythmia induced by low doses of sotalol: torsade de pointes or polymorphous ventricular tachycardia?].
    Ophoff N; Toker Y
    Z Kardiol; 1988 Jun; 77(6):393-7. PubMed ID: 3213144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac conduction disturbance after loperamide abuse.
    Marraffa JM; Holland MG; Sullivan RW; Morgan BW; Oakes JA; Wiegand TJ; Hodgman MJ
    Clin Toxicol (Phila); 2014 Nov; 52(9):952-7. PubMed ID: 25345436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loperamide cardiotoxicity: "A Brief Review".
    Akel T; Bekheit S
    Ann Noninvasive Electrocardiol; 2018 Mar; 23(2):e12505. PubMed ID: 29125226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left Ventricular Regional Wall Motion Abnormality in the Setting of Acute Loperamide Overdose.
    Bornstein K; Montrief T; Parris MA
    Clin Pract Cases Emerg Med; 2019 Aug; 3(3):262-266. PubMed ID: 31403100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
    Berling I; Isbister GK
    Ann Emerg Med; 2015 Aug; 66(2):154-64. PubMed ID: 25639523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.